Arcus South East Asia is a New York-based venture capital firm investing in oncology, biotechnology and broader life sciences companies, including biopharmaceutical developers, drug-delivery platforms and pre-approval medical device companies. The firm has Japan-linked investment activity and is relevant for founders in biotechnology, pharmaceuticals, medical devices and life sciences seeking venture funding.